Post-diagnosis diet, nutrition and cancer prognosis

Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer

Administering systemic chemotherapy improves survival for patients with resectable CRCLM

Immunotherapy significantly increases the number of patients free from bowel cancer

Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for centrally confirmed MSI-H/dMMR mCRC

Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma